Related Experiment Video
Updated: Jul 2, 2025
10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
1.3K
Developing CAR-immune cell therapy against SARS-CoV-2: Current status, challenges and prospects
Yizhao Chen1, Chong Liu1, Yilong Fang1
1Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Institute of Clinical Pharmacology, Anhui Medical University, Hefei 230032, China.
Biochemical Pharmacology
|February 19, 2024
Summary
Chimeric antigen receptor (CAR)-immune cell therapy shows promise for clearing tumors and viruses like SARS-CoV-2. This approach could potentially restore immune balance and combat COVID-19 by targeting the virus and regulating immune responses.
Area of Science:
- Immunology
- Virology
- Biotechnology
Background:
- Chimeric antigen receptor (CAR)-immune cell therapy has transformed cancer treatment by precisely targeting tumors.
- CAR-immune cells are being explored for their potential in viral clearance and immune system homeostasis.
- The COVID-19 pandemic, caused by SARS-CoV-2, highlights immune dysregulation, including overactive macrophages and compromised natural killer cells, leading to severe outcomes.
Purpose of the Study:
- To review the current research on CAR-immune cell therapy for SARS-CoV-2 infection.
- To discuss the potential of CAR-immune cells as a novel therapeutic strategy against COVID-19.
- To evaluate the feasibility, challenges, and future prospects of this innovative immunotherapy.
Main Methods:
- Literature review of studies investigating CAR-immune cells against SARS-CoV-2.
- Analysis of immune system dysregulation in COVID-19 patients.
- Discussion of CAR-immune cell mechanisms in viral clearance and immune modulation.
Main Results:
- CAR-immune cells demonstrate potential in targeting SARS-CoV-2 and modulating the immune response.
- Immune dysregulation in COVID-19 contributes to disease severity and impaired viral clearance.
- CAR-immune cell therapy offers a novel approach to address challenges posed by SARS-CoV-2 infection.
Conclusions:
- CAR-immune cell therapy presents a promising avenue for combating SARS-CoV-2 and its associated immune dysregulation.
- Further research is needed to overcome challenges and realize the full therapeutic potential of CAR-immune cells against COVID-19.
- This therapy could offer a new strategy for achieving viral clearance and restoring immune homeostasis in infected individuals.
Related Concept Videos
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
01:30Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:19Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K